Cancer Diagnostics Market - Forecast(2019 - 2024)

Report Code: HCR 0195 Report Format: PDF + Excel Database

According to the World Health Organization (WHO), the number of incidences of cancer mortality, globally, were 9.6 million people in 2018.[1] Increasing cancer incidences exert demand on the global cancer diagnostics market owing to increasing awareness and government initiatives for R&D in oncology devices and treatments. Cancer study and diagnosis technology has advanced significantly with development of broader and more precise methods such as transcriptomics, hybridization, next-generation sequencing (NGS), amplification-refractory mutation system (ARMS), genomics, proteomics, and many others. Screening tests have been proven to reduce the spread of cancer by detecting the root cause and minimizing severity, leading to the cancer diagnostics market growing rapidly and generating a lucrative revenue. The global cancer diagnostics market was valued at $135 billion in 2018, mainly due to therapeutic development and innovative cancer detection devices.

Globally, breast cancer, which is the second leading cause of death among women, requires effective screening tests for diagnosing and detecting abnormal cell growth in the region. Procedures such as biopsy, mammogram, and ultrasounds are widely used for breast cancer diagnosis, and this segment is estimated to grow at a CAGR of 28% through to 2025.

Cancer Diagnostics Market Outlook:

The American Cancer Society estimates that 2019 will see approximately 1,762,450 new incidences of cancer in the U.S.[2] The higher incidences of cancer, along with increasing medical tourism, advanced healthcare materials, growing population, and significant public awareness and government policies will effectively create demand and need for the cancer diagnostics market. Owing to the aforementioned factors, North America is leading the market demand for cancer diagnostics, and held a regional share of 37% in 2018. Cancer diagnosis remains an essential requirement in the modern oncology segment, as it cuts down on the additional treatment costs which would have arisen in the more advanced stages of cancer. Demand in the cancer diagnostics market is projected to increase at a CAGR of 6.2% during the forecast period 2019-2025.

Cancer Diagnostics Market Growth Drivers:

· Growing urbanization and increasing instances of cancer throughout the world are creating a huge demand for effective diagnosis, causing the global cancer diagnostics market to gradually gain traction.

· Rise in public welfare programs which create greater awareness among the population, and an upsurge in the medical tourism market is ballooning the scope for the cancer diagnostics market.

· Additionally, technologically advanced diagnostic devices, and government funding and policies for cancer treatment are propelling the cancer diagnostics market.

Cancer Diagnostics Market Challenges:

Despite the past few decades witnessing an unprecedented rise in cancer diagnosis, negative implications caused due to incorrect diagnoses have become a key barrier in the global market. Certain issues such as false positive and false negative reports, cost-inefficient diagnosis procedures, overdiagnosis, and exposure to ionizing radiation during diagnosis and treatment, have caused distrust among patients. Effective public outreach programs by government and private research agencies, and continuous innovation by companies developing oncology solutions with proven efficacy, will be able to overcome these challenges.

 
Cancer Diagnostics Market

Cancer Diagnostics Market Key Players:

Leading companies in the cancer diagnostics market include QIAGEN N.V., Cancer Diagnostics, Inc., Arquer Diagnostics Ltd, Inc., Becton, Illumina, Inc., GE Healthcare, BioMark Diagnostics Inc., Thermo Fisher Scientific, Inc., Biotheranostics, Inc., Dickinson and Company, Agilent Technologies, and others.

Cancer Diagnostics, Inc., manufactures diagnostic supplies and provides an array of equipment and specialized microtomes for enhancing the customer experience. These products include embedding centers, waterbaths, microscope slide printers, tissue processors, paraffin dispensers, strainers, and others.

Cancer Diagnostics Market Trends:

· Digital Molecular Breast Cancer Imaging:

Innovations in cancer diagnosis methods have considerably improved treatment procedures. Molecular imaging probes successfully detect responses from patients undergoing chemotherapy, and also  enable diagnosis of early-stage cancers. Gamma Medica Inc.’s LumaGEM® is one such revolutionary breast imaging system which can help women detect initial breast cancers, which usually remain undiagnosed due to the presence of thick tissue in this region.

· Avoiding Needless Surgery With Mir-THYpe:

Diagnosis of cancerous thyroid nodules is generally dealt with by surgeries to detect the malignancy of these cells, which majorly occur as benign. These unnecessary surgeries are not just an added expense, but also give rise to the lifelong need for regular hormone replacement. ONKOS Molecular Diagnostics have developed a new oncological diagnosis product - Mir-THYpe - which examines the micro-RNA molecules obtained during the prior fine needle aspiration (FNA) test, and identifies the necessity for surgical procedures.

Cancer Diagnostics Market Research Scope:

The base year of the study is 2018, with forecast done up to 2025. The study presents a thorough analysis of the competitive landscape, taking into account the market shares of the leading companies. It also provides information on unit shipments. These provide the key market participants with the necessary business intelligence and help them understand the future of the cancer diagnostics market. The assessment includes the forecast, an overview of the competitive structure, the market shares of the competitors, as well as the market trends, market demands, market drivers, market challenges, and product analysis. The market drivers and restraints have been assessed to fathom their impact over the forecast period. This report further identifies the key opportunities for growth while also detailing the key challenges and possible threats. The key areas of focus include the types of cancer diagnostics in cancer diagnostics market, and their specific applications in different areas.

Cancer Diagnostics Market: Industry Coverage:

The global cancer diagnostics market is segmented by type and technology. On the basis of type, categorization includes addiction, autoimmune disease, cancer, infectious disease, and other disease vaccines. Based on technology, the cancer diagnostics market can be divided into autologous and allogeneic vaccines.

The cancer diagnostics market also analyzes the major geographic regions for the market as well as the major countries for the market in these regions. The regions and countries covered in the study include:

•           North America: The U.S., Canada, Mexico

•           South America: Brazil, Venezuela, Argentina, Ecuador, Peru, Colombia, Costa Rica

•           Europe: The U.K., Germany, Italy, France, The Netherlands, Belgium, Spain, Denmark

•           APAC: China, Japan, Australia, South Korea, India, Taiwan, Malaysia, Hong Kong

•           Middle East and Africa: Israel, South Africa, Saudi Arabia


Reference:

[1] https://www.who.int/news-room/fact-sheets/detail/cancer

[2] https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/cancer-facts-figures-2019.html

1. Cancer Diagnostics Market - Overview
1.1. Definitions and Scope
2. Cancer Diagnostics Market - Executive summary
2.1. Market Revenue, Market Size and Key Trends by Company
2.2. Key Trends by type of Application
2.3. Key Trends segmented by Geography
3. Cancer Diagnostics Market 
3.1. Comparative analysis
3.1.1. Product Benchmarking - Top 10 companies
3.1.2. Top 5 Financials Analysis
3.1.3. Market Value split by Top 10 companies
3.1.4. Patent Analysis - Top 10 companies
3.1.5. Pricing Analysis 
4. Cancer Diagnostics Market – Startup companies Scenario Premium
4.1. Top 10 startup company Analysis by
4.1.1. Investment
4.1.2. Revenue
4.1.3. Market Shares
4.1.4. Market Size and Application Analysis
4.1.5. Venture Capital and Funding Scenario
5. Cancer Diagnostics Market – Industry Market Entry Scenario Premium
5.1. Regulatory Framework Overview
5.2. New Business and Ease of Doing business index
5.3. Case studies of successful ventures
5.4. Customer Analysis – Top 10 companies
6. Cancer Diagnostics Market Forces
6.1. Drivers
6.2. Constraints
6.3. Challenges
6.4. Porters five force model
6.4.1. Bargaining power of suppliers
6.4.2. Bargaining powers of customers
6.4.3. Threat of new entrants
6.4.4. Rivalry among existing players
6.4.5. Threat of substitutes 
7. Cancer Diagnostics Market -Strategic analysis
7.1. Value chain analysis
7.2. Opportunities analysis
7.3. Product life cycle
7.4. Suppliers and distributors Market Share
8. Cancer Diagnostics Market – By Product Type (Market Size -$Million / $Billion)
8.1. Market Size and Market Share Analysis 
8.2. Application Revenue and Trend Research
8.3. Product Segment Analysis
8.3.1. Next-generation Sequencing
8.3.2. Microarrays
8.3.3. PCR
8.3.4. Flow Cytometry
8.3.5. In situ Hybridization
8.3.6. Immunohistochemistry
8.3.7. Imaging Instruments (MRI, CT, PET, Ultrasound, Mammography)
8.3.8. Biopsy
9. Cancer Diagnostics Market – By Cancer Treated (Market Size -$Million / $Billion)
9.1. Breast Cancer
9.2. Prostate Cancer
9.3. Ovarian Cancer
9.4. Thyroid Cancer
9.5. Kidney Cancer
9.6. Blood Cancer
9.7. Colorectal Cancer
9.8. Liver Cancer
9.9. Pancreatic Cancer
9.10. Others
10. Cancer Diagnostics - By Geography (Market Size -$Million / $Billion)
10.1. Cancer Diagnostics Market - North America Segment Research
10.2. North America Market Research (Million / $Billion)
10.2.1. Segment type Size and Market Size Analysis 
10.2.2. Revenue and Trends
10.2.3. Application Revenue and Trends by type of Application
10.2.4. Company Revenue and Product Analysis
10.2.5. North America Product type and Application Market Size
10.2.5.1. U.S.
10.2.5.2. Canada 
10.2.5.3. Mexico 
10.2.5.4. Rest of North America
10.3. Cancer Diagnostics - South America Segment Research
10.4. South America Market Research (Market Size -$Million / $Billion)
10.4.1. Segment type Size and Market Size Analysis 
10.4.2. Revenue and Trends
10.4.3. Application Revenue and Trends by type of Application
10.4.4. Company Revenue and Product Analysis
10.4.5. South America Product type and Application Market Size
10.4.5.1. Brazil  
10.4.5.2. Venezuela
10.4.5.3. Argentina
10.4.5.4. Ecuador
10.4.5.5. Peru
10.4.5.6. Colombia 
10.4.5.7. Costa Rica
10.4.5.8. Rest of South America
10.5. Cancer Diagnostics - Europe Segment Research
10.6. Europe Market Research (Market Size -$Million / $Billion)
10.6.1. Segment type Size and Market Size Analysis 
10.6.2. Revenue and Trends
10.6.3. Application Revenue and Trends by type of Application
10.6.4. Company Revenue and Product Analysis
10.6.5. Europe Segment Product type and Application Market Size
10.6.5.1. U.K  
10.6.5.2. Germany 
10.6.5.3. Italy 
10.6.5.4. France
10.6.5.5. Netherlands
10.6.5.6. Belgium
10.6.5.7. Spain
10.6.5.8. Denmark
10.6.5.9. Rest of Europe
10.7. Cancer Diagnostics – APAC Segment Research
10.8. APAC Market Research (Market Size -$Million / $Billion)
10.8.1. Segment type Size and Market Size Analysis 
10.8.2. Revenue and Trends
10.8.3. Application Revenue and Trends by type of Application
10.8.4. Company Revenue and Product Analysis
10.8.5. APAC Segment – Product type and Application Market Size
10.8.5.1. China 
10.8.5.2. Australia
10.8.5.3. Japan 
10.8.5.4. South Korea
10.8.5.5. India
10.8.5.6. Taiwan
10.8.5.7. Malaysia
11. Cancer Diagnostics Market - Entropy
11.1. New product launches
11.2. M&A's, collaborations, JVs and partnerships
12. Cancer Diagnostics Market – Industry / Segment Competition landscape Premium
12.1. Market Share Analysis
12.1.1. Market Share by Country- Top companies
12.1.2. Market Share by Region- Top 10 companies
12.1.3. Market Share by type of Application – Top 10 companies
12.1.4. Market Share by type of Product / Product category- Top 10 companies
12.1.5. Market Share at global level- Top 10 companies
12.1.6. Best Practises for companies
13. Cancer Diagnostics Market – Key Company List by Country Premium
14. Cancer Diagnostics Market Company Analysis
14.1. Market Share, Company Revenue, Products, M&A, Developments
14.2. Thermo Fisher Scientific, Inc.
14.3. GE Healthcare (A Subsidiary of General Electric Company) 
14.4. Abbott Laboratories, Inc.
14.5. Becton, Dickinson and Company
14.6. Siemens Healthcare
14.7. Agilent Technologies, Inc.
14.8. Roche
14.9. C.R. Bard, Inc.
14.10. Illumina, Inc.
14.11. Boehringer-Ingelheim
14.12. Company 11
14.13. Company 12
14.14. Company 13 and more
"*Financials would be provided on a best efforts basis for private companies"
15. Cancer Diagnostics Market -Appendix
15.1. Abbreviations
15.2. Sources
16. Cancer Diagnostics Market -Methodology Premium
16.1. Research Methodology
16.1.1. Company Expert Interviews
16.1.2. Industry Databases
16.1.3. Associations
16.1.4. Company News
16.1.5. Company Annual Reports
16.1.6. Application Trends
16.1.7. New Products and Product database
16.1.8. Company Transcripts
16.1.9. R&D Trends
16.1.10. Key Opinion Leaders Interviews
16.1.11. Supply and Demand Trends
List of Tables:

Table 1: Cancer Diagnostics Market Overview 2019-2024
Table 2: Cancer Diagnostics Market Leader Analysis 2018-2019 (US$)
Table 3: Cancer Diagnostics Market Product Analysis 2018-2019 (US$)
Table 4: Cancer Diagnostics Market End User Analysis 2018-2019 (US$)
Table 5: Cancer Diagnostics Market Patent Analysis 2013-2018* (US$)
Table 6: Cancer Diagnostics Market Financial Analysis 2018-2019 (US$)
Table 7: Cancer Diagnostics Market Driver Analysis 2018-2019 (US$)
Table 8: Cancer Diagnostics Market Challenges Analysis 2018-2019 (US$)
Table 9: Cancer Diagnostics Market Constraint Analysis 2018-2019 (US$)
Table 10: Cancer Diagnostics Market Supplier Bargaining Power Analysis 2018-2019 (US$)
Table 11: Cancer Diagnostics Market Buyer Bargaining Power Analysis 2018-2019 (US$)
Table 12: Cancer Diagnostics Market Threat of Substitutes Analysis 2018-2019 (US$)
Table 13: Cancer Diagnostics Market Threat of New Entrants Analysis 2018-2019 (US$)
Table 14: Cancer Diagnostics Market Degree of Competition Analysis 2018-2019 (US$)
Table 15: Cancer Diagnostics Market Value Chain Analysis 2018-2019 (US$)
Table 16: Cancer Diagnostics Market Pricing Analysis 2019-2024 (US$)
Table 17: Cancer Diagnostics Market Opportunities Analysis 2019-2024 (US$)
Table 18: Cancer Diagnostics Market Product Life Cycle Analysis 2019-2024 (US$)
Table 19: Cancer Diagnostics Market Supplier Analysis 2018-2019 (US$)
Table 20: Cancer Diagnostics Market Distributor Analysis 2018-2019 (US$)
Table 21: Cancer Diagnostics Market Trend Analysis 2018-2019 (US$)
Table 22: Cancer Diagnostics Market Size 2018 (US$)
Table 23: Cancer Diagnostics Market Forecast Analysis 2019-2024 (US$)
Table 24: Cancer Diagnostics Market Sales Forecast Analysis 2019-2024 (Units)
Table 25: Cancer Diagnostics Market, Revenue & Volume, By Product Type, 2019-2024 ($)
Table 26: Cancer Diagnostics Market By Product Type, Revenue & Volume, By Next-generation Sequencing, 2019-2024 ($)
Table 27: Cancer Diagnostics Market By Product Type, Revenue & Volume, By Microarrays, 2019-2024 ($)
Table 28: Cancer Diagnostics Market By Product Type, Revenue & Volume, By PCR, 2019-2024 ($)
Table 29: Cancer Diagnostics Market By Product Type, Revenue & Volume, By Flow Cytometry, 2019-2024 ($)
Table 30: Cancer Diagnostics Market By Product Type, Revenue & Volume, By In situ Hybridization, 2019-2024 ($)
Table 31: Cancer Diagnostics Market, Revenue & Volume, By Cancer Treated, 2019-2024 ($)
Table 32: Cancer Diagnostics Market By Cancer Treated, Revenue & Volume, By Breast Cancer, 2019-2024 ($)
Table 33: Cancer Diagnostics Market By Cancer Treated, Revenue & Volume, By Prostate Cancer, 2019-2024 ($)
Table 34: Cancer Diagnostics Market By Cancer Treated, Revenue & Volume, By Ovarian Cancer, 2019-2024 ($)
Table 35: Cancer Diagnostics Market By Cancer Treated, Revenue & Volume, By Thyroid Cancer, 2019-2024 ($)
Table 36: Cancer Diagnostics Market By Cancer Treated, Revenue & Volume, By Kidney Cancer, 2019-2024 ($)
Table 37: North America Cancer Diagnostics Market, Revenue & Volume, By Product Type, 2019-2024 ($)
Table 38: North America Cancer Diagnostics Market, Revenue & Volume, By Cancer Treated, 2019-2024 ($)
Table 39: South america Cancer Diagnostics Market, Revenue & Volume, By Product Type, 2019-2024 ($)
Table 40: South america Cancer Diagnostics Market, Revenue & Volume, By Cancer Treated, 2019-2024 ($)
Table 41: Europe Cancer Diagnostics Market, Revenue & Volume, By Product Type, 2019-2024 ($)
Table 42: Europe Cancer Diagnostics Market, Revenue & Volume, By Cancer Treated, 2019-2024 ($)
Table 43: APAC Cancer Diagnostics Market, Revenue & Volume, By Product Type, 2019-2024 ($)
Table 44: APAC Cancer Diagnostics Market, Revenue & Volume, By Cancer Treated, 2019-2024 ($)
Table 45: Middle East & Africa Cancer Diagnostics Market, Revenue & Volume, By Product Type, 2019-2024 ($)
Table 46: Middle East & Africa Cancer Diagnostics Market, Revenue & Volume, By Cancer Treated, 2019-2024 ($)
Table 47: Russia Cancer Diagnostics Market, Revenue & Volume, By Product Type, 2019-2024 ($)
Table 48: Russia Cancer Diagnostics Market, Revenue & Volume, By Cancer Treated, 2019-2024 ($)
Table 49: Israel Cancer Diagnostics Market, Revenue & Volume, By Product Type, 2019-2024 ($)
Table 50: Israel Cancer Diagnostics Market, Revenue & Volume, By Cancer Treated, 2019-2024 ($)
Table 51: Top Companies 2018 (US$)Cancer Diagnostics Market, Revenue & Volume
Table 52: Product Launch 2018-2019Cancer Diagnostics Market, Revenue & Volume
Table 53: Mergers & Acquistions 2018-2019Cancer Diagnostics Market, Revenue & Volume


List of Figures:

Figure 1: Overview of Cancer Diagnostics Market 2019-2024
Figure 2: Market Share Analysis for Cancer Diagnostics Market 2018 (US$)
Figure 3: Product Comparison in Cancer Diagnostics Market 2018-2019 (US$)
Figure 4: End User Profile for Cancer Diagnostics Market 2018-2019 (US$)
Figure 5: Patent Application and Grant in Cancer Diagnostics Market 2013-2018* (US$)
Figure 6: Top 5 Companies Financial Analysis in Cancer Diagnostics Market 2018-2019 (US$)
Figure 7: Market Entry Strategy in Cancer Diagnostics Market 2018-2019
Figure 8: Ecosystem Analysis in Cancer Diagnostics Market 2018
Figure 9: Average Selling Price in Cancer Diagnostics Market 2019-2024
Figure 10: Top Opportunites in Cancer Diagnostics Market 2018-2019
Figure 11: Market Life Cycle Analysis in Cancer Diagnostics Market
Figure 12: GlobalBy Product TypeCancer Diagnostics Market Revenue, 2019-2024 ($)
Figure 13: GlobalBy Cancer TreatedCancer Diagnostics Market Revenue, 2019-2024 ($)
Figure 14: Global Cancer Diagnostics Market - By Geography
Figure 15: Global Cancer Diagnostics Market Value & Volume, By Geography, 2019-2024 ($) 
Figure 16: Global Cancer Diagnostics Market CAGR, By Geography, 2019-2024 (%)
Figure 17: North America Cancer Diagnostics Market Value & Volume, 2019-2024 ($)
Figure 18: US Cancer Diagnostics Market Value & Volume, 2019-2024 ($)
Figure 19: US GDP and Population, 2018-2019 ($)
Figure 20: US GDP – Composition of 2018, By Sector of Origin
Figure 21: US Export and Import Value & Volume, 2018-2019 ($)
Figure 22: Canada Cancer Diagnostics Market Value & Volume, 2019-2024 ($)
Figure 23: Canada GDP and Population, 2018-2019 ($)
Figure 24: Canada GDP – Composition of 2018, By Sector of Origin
Figure 25: Canada Export and Import Value & Volume, 2018-2019 ($)
Figure 26: Mexico Cancer Diagnostics Market Value & Volume, 2019-2024 ($)
Figure 27: Mexico GDP and Population, 2018-2019 ($)
Figure 28: Mexico GDP – Composition of 2018, By Sector of Origin
Figure 29: Mexico Export and Import Value & Volume, 2018-2019 ($)
Figure 30: South America Cancer Diagnostics Market Value & Volume, 2019-2024 ($)
Figure 31: Brazil Cancer Diagnostics Market Value & Volume, 2019-2024 ($)
Figure 32: Brazil GDP and Population, 2018-2019 ($)
Figure 33: Brazil GDP – Composition of 2018, By Sector of Origin
Figure 34: Brazil Export and Import Value & Volume, 2018-2019 ($)
Figure 35: Venezuela Cancer Diagnostics Market Value & Volume, 2019-2024 ($)
Figure 36: Venezuela GDP and Population, 2018-2019 ($)
Figure 37: Venezuela GDP – Composition of 2018, By Sector of Origin
Figure 38: Venezuela Export and Import Value & Volume, 2018-2019 ($)
Figure 39: Argentina Cancer Diagnostics Market Value & Volume, 2019-2024 ($)
Figure 40: Argentina GDP and Population, 2018-2019 ($)
Figure 41: Argentina GDP – Composition of 2018, By Sector of Origin
Figure 42: Argentina Export and Import Value & Volume, 2018-2019 ($)
Figure 43: Ecuador Cancer Diagnostics Market Value & Volume, 2019-2024 ($)
Figure 44: Ecuador GDP and Population, 2018-2019 ($)
Figure 45: Ecuador GDP – Composition of 2018, By Sector of Origin
Figure 46: Ecuador Export and Import Value & Volume, 2018-2019 ($)
Figure 47: Peru Cancer Diagnostics Market Value & Volume, 2019-2024 ($)
Figure 48: Peru GDP and Population, 2018-2019 ($)
Figure 49: Peru GDP – Composition of 2018, By Sector of Origin
Figure 50: Peru Export and Import Value & Volume, 2018-2019 ($)
Figure 51: Colombia Cancer Diagnostics Market Value & Volume, 2019-2024 ($)
Figure 52: Colombia GDP and Population, 2018-2019 ($)
Figure 53: Colombia GDP – Composition of 2018, By Sector of Origin
Figure 54: Colombia Export and Import Value & Volume, 2018-2019 ($)
Figure 55: Costa Rica Cancer Diagnostics Market Value & Volume, 2019-2024 ($)
Figure 56: Costa Rica GDP and Population, 2018-2019 ($)
Figure 57: Costa Rica GDP – Composition of 2018, By Sector of Origin
Figure 58: Costa Rica Export and Import Value & Volume, 2018-2019 ($)
Figure 59: Europe Cancer Diagnostics Market Value & Volume, 2019-2024 ($)
Figure 60: U.K Cancer Diagnostics Market Value & Volume, 2019-2024 ($)
Figure 61: U.K GDP and Population, 2018-2019 ($)
Figure 62: U.K GDP – Composition of 2018, By Sector of Origin
Figure 63: U.K Export and Import Value & Volume, 2018-2019 ($)
Figure 64: Germany Cancer Diagnostics Market Value & Volume, 2019-2024 ($)
Figure 65: Germany GDP and Population, 2018-2019 ($)
Figure 66: Germany GDP – Composition of 2018, By Sector of Origin
Figure 67: Germany Export and Import Value & Volume, 2018-2019 ($)
Figure 68: Italy Cancer Diagnostics Market Value & Volume, 2019-2024 ($)
Figure 69: Italy GDP and Population, 2018-2019 ($)
Figure 70: Italy GDP – Composition of 2018, By Sector of Origin
Figure 71: Italy Export and Import Value & Volume, 2018-2019 ($)
Figure 72: France Cancer Diagnostics Market Value & Volume, 2019-2024 ($)
Figure 73: France GDP and Population, 2018-2019 ($)
Figure 74: France GDP – Composition of 2018, By Sector of Origin
Figure 75: France Export and Import Value & Volume, 2018-2019 ($)
Figure 76: Netherlands Cancer Diagnostics Market Value & Volume, 2019-2024 ($)
Figure 77: Netherlands GDP and Population, 2018-2019 ($)
Figure 78: Netherlands GDP – Composition of 2018, By Sector of Origin
Figure 79: Netherlands Export and Import Value & Volume, 2018-2019 ($)
Figure 80: Belgium Cancer Diagnostics Market Value & Volume, 2019-2024 ($)
Figure 81: Belgium GDP and Population, 2018-2019 ($)
Figure 82: Belgium GDP – Composition of 2018, By Sector of Origin
Figure 83: Belgium Export and Import Value & Volume, 2018-2019 ($)
Figure 84: Spain Cancer Diagnostics Market Value & Volume, 2019-2024 ($)
Figure 85: Spain GDP and Population, 2018-2019 ($)
Figure 86: Spain GDP – Composition of 2018, By Sector of Origin
Figure 87: Spain Export and Import Value & Volume, 2018-2019 ($)
Figure 88: Denmark Cancer Diagnostics Market Value & Volume, 2019-2024 ($)
Figure 89: Denmark GDP and Population, 2018-2019 ($)
Figure 90: Denmark GDP – Composition of 2018, By Sector of Origin
Figure 91: Denmark Export and Import Value & Volume, 2018-2019 ($)
Figure 92: APAC Cancer Diagnostics Market Value & Volume, 2019-2024 ($)
Figure 93: China Cancer Diagnostics Market Value & Volume, 2019-2024
Figure 94: China GDP and Population, 2018-2019 ($)
Figure 95: China GDP – Composition of 2018, By Sector of Origin
Figure 96: China Export and Import Value & Volume, 2018-2019 ($)Cancer Diagnostics Market China Export and Import Value & Volume, 2018-2019 ($)
Figure 97: Australia Cancer Diagnostics Market Value & Volume, 2019-2024 ($)
Figure 98: Australia GDP and Population, 2018-2019 ($)
Figure 99: Australia GDP – Composition of 2018, By Sector of Origin
Figure 100: Australia Export and Import Value & Volume, 2018-2019 ($)
Figure 101: South Korea Cancer Diagnostics Market Value & Volume, 2019-2024 ($)
Figure 102: South Korea GDP and Population, 2018-2019 ($)
Figure 103: South Korea GDP – Composition of 2018, By Sector of Origin
Figure 104: South Korea Export and Import Value & Volume, 2018-2019 ($)
Figure 105: India Cancer Diagnostics Market Value & Volume, 2019-2024 ($)
Figure 106: India GDP and Population, 2018-2019 ($)
Figure 107: India GDP – Composition of 2018, By Sector of Origin
Figure 108: India Export and Import Value & Volume, 2018-2019 ($)
Figure 109: Taiwan Cancer Diagnostics Market Value & Volume, 2019-2024 ($)
Figure 110: Taiwan GDP and Population, 2018-2019 ($)
Figure 111: Taiwan GDP – Composition of 2018, By Sector of Origin
Figure 112: Taiwan Export and Import Value & Volume, 2018-2019 ($)
Figure 113: Malaysia Cancer Diagnostics Market Value & Volume, 2019-2024 ($)
Figure 114: Malaysia GDP and Population, 2018-2019 ($)
Figure 115: Malaysia GDP – Composition of 2018, By Sector of Origin
Figure 116: Malaysia Export and Import Value & Volume, 2018-2019 ($)
Figure 117: Hong Kong Cancer Diagnostics Market Value & Volume, 2019-2024 ($)
Figure 118: Hong Kong GDP and Population, 2018-2019 ($)
Figure 119: Hong Kong GDP – Composition of 2018, By Sector of Origin
Figure 120: Hong Kong Export and Import Value & Volume, 2018-2019 ($)
Figure 121: Middle East & Africa Cancer Diagnostics Market Middle East & Africa 3D Printing Market Value & Volume, 2019-2024 ($)
Figure 122: Russia Cancer Diagnostics Market Value & Volume, 2019-2024 ($)
Figure 123: Russia GDP and Population, 2018-2019 ($)
Figure 124: Russia GDP – Composition of 2018, By Sector of Origin
Figure 125: Russia Export and Import Value & Volume, 2018-2019 ($)
Figure 126: Israel Cancer Diagnostics Market Value & Volume, 2019-2024 ($)
Figure 127: Israel GDP and Population, 2018-2019 ($)
Figure 128: Israel GDP – Composition of 2018, By Sector of Origin
Figure 129: Israel Export and Import Value & Volume, 2018-2019 ($)
Figure 130: Entropy Share, By Strategies, 2018-2019* (%)Cancer Diagnostics Market
Figure 131: Developments, 2018-2019*Cancer Diagnostics Market
Figure 132: Company 1 Cancer Diagnostics Market Net Revenue, By Years, 2018-2019* ($)
Figure 133: Company 1 Cancer Diagnostics Market Net Revenue Share, By Business segments, 2018 (%)
Figure 134: Company 1 Cancer Diagnostics Market Net Sales Share, By Geography, 2018 (%)
Figure 135: Company 2 Cancer Diagnostics Market Net Revenue, By Years, 2018-2019* ($)
Figure 136: Company 2 Cancer Diagnostics Market Net Revenue Share, By Business segments, 2018 (%)
Figure 137: Company 2 Cancer Diagnostics Market Net Sales Share, By Geography, 2018 (%)
Figure 138: Company 3 Cancer Diagnostics Market Net Revenue, By Years, 2018-2019* ($)
Figure 139: Company 3 Cancer Diagnostics Market Net Revenue Share, By Business segments, 2018 (%)
Figure 140: Company 3 Cancer Diagnostics Market Net Sales Share, By Geography, 2018 (%)
Figure 141: Company 4 Cancer Diagnostics Market Net Revenue, By Years, 2018-2019* ($)
Figure 142: Company 4 Cancer Diagnostics Market Net Revenue Share, By Business segments, 2018 (%)
Figure 143: Company 4 Cancer Diagnostics Market Net Sales Share, By Geography, 2018 (%)
Figure 144: Company 5 Cancer Diagnostics Market Net Revenue, By Years, 2018-2019* ($)
Figure 145: Company 5 Cancer Diagnostics Market Net Revenue Share, By Business segments, 2018 (%)
Figure 146: Company 5 Cancer Diagnostics Market Net Sales Share, By Geography, 2018 (%)
Figure 147: Company 6 Cancer Diagnostics Market Net Revenue, By Years, 2018-2019* ($)
Figure 148: Company 6 Cancer Diagnostics Market Net Revenue Share, By Business segments, 2018 (%)
Figure 149: Company 6 Cancer Diagnostics Market Net Sales Share, By Geography, 2018 (%)
Figure 150: Company 7 Cancer Diagnostics Market Net Revenue, By Years, 2018-2019* ($)
Figure 151: Company 7 Cancer Diagnostics Market Net Revenue Share, By Business segments, 2018 (%)
Figure 152: Company 7 Cancer Diagnostics Market Net Sales Share, By Geography, 2018 (%)
Figure 153: Company 8 Cancer Diagnostics Market Net Revenue, By Years, 2018-2019* ($)
Figure 154: Company 8 Cancer Diagnostics Market Net Revenue Share, By Business segments, 2018 (%)
Figure 155: Company 8 Cancer Diagnostics Market Net Sales Share, By Geography, 2018 (%)
Figure 156: Company 9 Cancer Diagnostics Market Net Revenue, By Years, 2018-2019* ($)
Figure 157: Company 9 Cancer Diagnostics Market Net Revenue Share, By Business segments, 2018 (%)
Figure 158: Company 9 Cancer Diagnostics Market Net Sales Share, By Geography, 2018 (%)
Figure 159: Company 10 Cancer Diagnostics Market Net Revenue, By Years, 2018-2019* ($)
Figure 160: Company 10 Cancer Diagnostics Market Net Revenue Share, By Business segments, 2018 (%)
Figure 161: Company 10 Cancer Diagnostics Market Net Sales Share, By Geography, 2018 (%)
Figure 162: Company 11 Cancer Diagnostics Market Net Revenue, By Years, 2018-2019* ($)
Figure 163: Company 11 Cancer Diagnostics Market Net Revenue Share, By Business segments, 2018 (%)
Figure 164: Company 11 Cancer Diagnostics Market Net Sales Share, By Geography, 2018 (%)
Figure 165: Company 12 Cancer Diagnostics Market Net Revenue, By Years, 2018-2019* ($)
Figure 166: Company 12 Cancer Diagnostics Market Net Revenue Share, By Business segments, 2018 (%)
Figure 167: Company 12 Cancer Diagnostics Market Net Sales Share, By Geography, 2018 (%)
Figure 168: Company 13 Cancer Diagnostics Market Net Revenue, By Years, 2018-2019* ($)
Figure 169: Company 13 Cancer Diagnostics Market Net Revenue Share, By Business segments, 2018 (%)
Figure 170: Company 13 Cancer Diagnostics Market Net Sales Share, By Geography, 2018 (%)
Figure 171: Company 14 Cancer Diagnostics Market Net Revenue, By Years, 2018-2019* ($)
Figure 172: Company 14 Cancer Diagnostics Market Net Revenue Share, By Business segments, 2018 (%)
Figure 173: Company 14 Cancer Diagnostics Market Net Sales Share, By Geography, 2018 (%)
Figure 174: Company 15 Cancer Diagnostics Market Net Revenue, By Years, 2018-2019* ($)
Figure 175: Company 15 Cancer Diagnostics Market Net Revenue Share, By Business segments, 2018 (%)
Figure 176: Company 15 Cancer Diagnostics Market Net Sales Share, By Geography, 2018 (%)